TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 3 | 1 | 1 | 2 | -14 | -4 | -13 | -5 |
| S | %wins | 33 | 33 | 33 | 67 | 100 | 100 | 61 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/1/10 15:49 | 4/1/10 | HGSI | Human Genome Sciences Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Stump David C | MD | O | Exec. VP | S.d | -1,044 | 30.72 | 33 | -34 | -63 | 20 | D | 393 | 999 | 60 | -2 | 3 | -8 | -3 | -2 | 2 | 7 | -8 | -25 | -5 | -9 |
3/2/10 13:15 | 3/1/10 | HGSI | Human Genome Sciences Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Stump David C | MD | O | Exec. VP | S.d | -1,404 | 28.07 | 33 | -50 | -72 | 20 | D | 385 | 999 | 57 | 7 | 2 | 16 | 2 | 4 | 1 | 4 | 4 | -17 | -2 | -16 |
2/2/10 17:17 | 2/2/10 | HGSI | Human Genome Sciences Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Stump David C | MD | O | Exec. VP | S.d | -1,370 | 27.40 | 33 | -50 | -72 | 20 | D | 394 | 999 | 93 | 38 | 1 | -9 | -1 | -2 | -1 | -8 | 11 | 1 | -6 | -14 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |